Invivyd’s monoclonal antibody can cut the risk of contracting Covid-19 in both healthy and immunocompromised people, according to the latest exploratory analysis from a Phase …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
As Novo Nordisk hauls in huge sales from its popular GLP-1 products, the company is thinking about a future beyond obesity and diabetes. During a
Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC